| Amanta Healthcare Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 544502 |
NSE Symbol : AMANTA |
P/E(TTM) : 28.53 |
|
ISIN Demat : INE084K01015 |
Div & Yield% : 0.00 |
EPS(TTM) : 3.60 |
|
Book Value(₹) : 54.26 |
Market Cap(₹Cr) : 398.78 |
Face Value(₹) : 10.00 |
| Particulars | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 70.89 | 65.31 | 72.06 | 67.81 | 66.73 | 68.10 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 70.89 | 65.31 | 72.06 | 67.81 | 66.73 | 68.10 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 0.07 | 0.96 | 0.16 | 0.87 | 0.21 | 0.15 |
| Total Income | 70.96 | 66.27 | 72.22 | 68.68 | 66.94 | 68.24 |
| Total Expenditure | 58.87 | 50.41 | 53.10 | 54.39 | 52.85 | 54.70 |
| PBIDT | 12.09 | 15.85 | 19.13 | 14.30 | 14.09 | 13.54 |
| Interest | 5.15 | 6.29 | 6.28 | 5.90 | 6.32 | 9.45 |
| PBDT | 6.94 | 9.57 | 12.84 | 8.40 | 7.77 | 4.10 |
| Depreciation | 4.66 | 4.64 | 4.69 | 4.51 | 4.60 | 4.60 |
| Tax | 1.97 | 1.65 | 1.81 | 1.12 | 0.66 | 0.00 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -0.90 | -0.23 | 0.38 | 0.13 | 0.25 | -0.14 |
| Reported Profit After Tax | 1.21 | 3.51 | 5.96 | 2.65 | 2.26 | -0.36 |
| Extra-ordinary Items | -0.66 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 1.87 | 3.51 | 5.96 | 2.65 | 2.26 | -0.36 |
| EPS (Unit Curr.) | 0.35 | 1.22 | 2.11 | 0.92 | 0.80 | -0.13 |
| EPS (Adj) (Unit Curr.) | 0.35 | 1.22 | 2.11 | 0.92 | 0.80 | -0.13 |
| Calculated EPS (Unit Curr.) | 0.31 | 1.22 | 2.07 | 9.36 | 7.98 | -1.28 |
| Calculated EPS (Adj) (Unit Curr.) | 0.31 | 1.22 | 2.07 | 9.36 | 7.98 | -1.28 |
| Calculated EPS (Ann.) (Unit Curr.) | 1.24 | 4.87 | 8.27 | 37.44 | 31.93 | -5.12 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 1.24 | 4.87 | 8.27 | 37.44 | 31.93 | -5.12 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 38.83 | 28.83 | 28.83 | 2.83 | 2.83 | 2.83 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 17.05 | 24.27 | 26.55 | 21.09 | 21.11 | 19.88 |
| PBDTM(%) | 9.79 | 14.65 | 17.82 | 12.39 | 11.64 | 6.02 |
| PATM(%) | 1.71 | 5.37 | 8.27 | 3.91 | 3.39 | -0.53 |